LSX Congress USA 2026

 

LSX USA brings together biotech leaders, pharma BD teams and active investors from across North America and beyond for focused conversations around investment, partnering and growth.

Taking place in Boston this September, the Congress offers life science companies the opportunity to build visibility, connect with investors and engage pharma teams exploring innovation, licensing and strategic partnerships.

This year’s faculty includes senior leaders from Boehringer Ingelheim, Eli Lilly, AbbVie, Blackstone Life Sciences, Johnson & Johnson, GSK, Ipsen, Servier, Astellas Pharma, BNP Paribas Asset Management, Panacea Capital and Vida Ventures.

 

Use code BPA15 to save 15%.

More Info

---

---